AstraZeneca and Oxford University manufacturing error clouds Covid-19 vaccine study results
AstraZeneca and Oxford University have acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine.
In the low-dose group, AstraZeneca said, the Covid-19 vaccine appeared to be 90 per cent effective.